Open AccessComparative Study of Vaccine Safety Surveillance on Covid-19
Author(s) -
Akshat Seth,
Sunil Kumar,
Surabhi Dwivedi,
Anil Kumar Shrivastava
Publication year - 2021
Publication title -
international journal of pharmaceutical sciences review and research
Language(s) - English
Resource type - Journals
ISSN - 0976-044X
DOI - 10.47583/ijpsrr.2021.v71i01.005
Subject(s) - pandemic , medicine , covid-19 , immunization , adverse effect , virology , infectious disease (medical specialty) , environmental health , medical emergency , intensive care medicine , immunology , disease , pathology , antigen
Vaccine among people globally preparations must be made within countries for covid-19 vaccine safety surveillance on an urgentbasis. Safety surveillance must be capable of investigating adverse event of special interest (AESI) and adverse event followingimmunization to determine a change in the benefit-risk profile of the vaccine. COVID-19 vaccine is the most important tool to stemthe pandemic. WHO emergency use listing, while using regulatory pathway through national regulatory authorities. Vaccine safetycommunication plan should be developed. Expending the global vaccine safety system to meet the needs of covid-19 and otheremergency and routine use vaccine is a priority currently. The protective efficacy and the short term and long-term side effect of thevaccine are of major concern. Various strategies have been designed the covid-19 pandemic. The highly infectious corona virus disease2019 associate with me pathogenic severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) has spread to become a globalpandemic. The development of covid-19 vaccine is crucial for the world to return to pre-pandemic normalcy and the collective globaleffort has been invested into protective against SARS-CoV2.